Clinical Trial 35928


Oakland, CA 94607

Study Summary:

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia.

Qualified Participants Must:

• Be 18 years of age and older (Adult, Senior)
• Have a clinical diagnosis of schizophrenia with a minimum duration of 1 year
• Live within 100 miles of the study location (within the greater Los Angeles area)

Qualified Participants May Receive:

Qualified participants may receive compensation for time and travel. for more information on compensation please contact CNS.

Study is Available At:

Pacific Research Partners
901 Clay Street
Oakland, CA 94607
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 100 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.